Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | ZTS | TAK | UTHR | CTLT |
| Company | Neurocrine Bioscienc | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | United Therapeutic | Catalent Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NYSE |
| Open | 140.90 | 170.45 | 13.34 | 260.33 | 56.34 |
| High | 141.88 | 171.69 | 13.41 | 262.51 | 56.63 |
| Low | 139.23 | 166.95 | 13.30 | 255.93 | 56.18 |
| Last | 140.71 | 167.07 | 13.37 | 262.40 | 56.50 |
| Change | +0.88 | -0.16 | +0.10 | +4.27 | +0.16 |
| % Change | +0.63% | -0.10% | +0.75% | +1.65% | +0.28% |
| Volume | 616,500 | 3,007,100 | 1,333,900 | 779,500 | 1,712,900 |
| 20-Day Average Volume | 803,360 | 4,574,185 | 1,625,240 | 557,520 | 1,599,560 |
| Previous Close | 139.83 | 167.23 | 13.27 | 258.13 | 56.34 |
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 136.80 | 156.63 | 13.30 | 239.11 | 56.19 |
| 20-Day Raw Stochastic | 70.11% | 82.82% | 47.40% | 99.66% | 60.68% |
| 20-Day Relative Strength | 54.80% | 52.97% | 44.05% | 67.92% | 54.92% |
| Weighted Alpha | +45.16 | -11.45 | -20.15 | +26.59 | +42.66 |
| Today's Opinion | 88% Buy | 56% Sell | 88% Sell | 88% Buy | 56% Buy |
| Previous Opinion | 88% Buy | 64% Sell | 100% Sell | 88% Buy | 56% Buy |
| Last Month's Opinion | 88% Buy | 56% Sell | 88% Sell | 16% Buy | 96% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.47% since 04/26/24 | +5.46% since 04/26/24 | +2.61% since 04/26/24 | +12.21% since 04/26/24 | +1.04% since 04/26/24 |
| Low | 136.01 on 05/01/24 | 158.04 on 05/01/24 | 13.08 on 05/01/24 | 233.31 on 04/30/24 | 55.75 on 05/01/24 |
| High | 145.22 on 05/01/24 | 171.69 on 05/03/24 | 13.41 on 05/03/24 | 262.51 on 05/03/24 | 56.63 on 05/03/24 |
| 1-Month | |||||
| %Chg | +2.27% since 04/03/24 | +2.52% since 04/03/24 | -1.18% since 04/03/24 | +13.49% since 04/03/24 | -0.32% since 04/03/24 |
| Low | 130.13 on 04/19/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 229.72 on 04/04/24 | 55.42 on 04/19/24 |
| High | 145.22 on 05/01/24 | 171.69 on 05/03/24 | 13.77 on 04/08/24 | 262.51 on 05/03/24 | 57.20 on 04/11/24 |
| 3-Month | |||||
| %Chg | -0.73% since 02/02/24 | -11.62% since 02/02/24 | -6.37% since 02/02/24 | +22.96% since 02/02/24 | +3.65% since 02/02/24 |
| Low | 128.00 on 02/07/24 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 208.62 on 02/08/24 | 55.42 on 04/19/24 |
| High | 148.37 on 03/21/24 | 200.53 on 02/29/24 | 14.88 on 02/27/24 | 262.51 on 05/03/24 | 60.20 on 02/05/24 |
| 6-Month | |||||
| %Chg | +25.14% since 11/03/23 | +2.98% since 11/03/23 | -4.57% since 11/03/23 | +16.92% since 11/03/23 | +60.19% since 11/03/23 |
| Low | 103.63 on 11/10/23 | 144.80 on 04/22/24 | 13.01 on 04/26/24 | 208.62 on 02/08/24 | 32.38 on 11/13/23 |
| High | 148.37 on 03/21/24 | 201.92 on 12/14/23 | 15.07 on 01/12/24 | 262.51 on 05/03/24 | 60.20 on 02/05/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,160,632 | 76,410,976 | 42,313,872 | 11,641,639 | 10,225,030 |
| Shares Outstanding, K | 100,637 | 457,359 | 3,164,837 | 44,366 | 180,974 |
| Annual Sales | 1,887,100,000 | 8,544,000,000 | 29,803,340,000 | 2,327,500,000 | 4,263,000,000 |
| Annual Net Income | 249,700,000 | 2,344,000,000 | 2,345,930,000 | 984,800,000 | -256,000,000 |
| Last Quarter Sales | 515,200,000 | 2,213,000,000 | 7,556,070,000 | 614,700,000 | 1,024,000,000 |
| Last Quarter Net Income | 147,700,000 | 525,000,000 | 718,900,000 | 217,100,000 | -206,000,000 |
| 60-Month Beta | 0.28 | 0.86 | 0.56 | 0.54 | 1.18 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.42 on 05/01/24 | 1.38 on 05/02/24 | 0.51 on 02/01/24 | 6.17 on 05/01/24 | -0.24 on 02/09/24 |
| Latest Earnings Date | 05/01/24 | 05/02/24 | 05/09/24 | 05/01/24 | 06/10/24 |
| Most Recent Dividend | N/A | 0.432 on 04/18/24 | 0.261 on 09/28/23 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 04/18/24 | 09/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 38.52 | 31.03 | 6.81 | 12.20 | 0.00 |